Product/Composition:- | Oxycodone injectable |
---|---|
Strength:- | 10 mg/mL or 20 mg/mL in vials |
Form:- | Injectable Solution (IM/IV) |
Reference Brands:- | OxyContin, Roxicodone, Oxymorphone(US); OxyContin, OxyNorm(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Oxycodone injectable activates mu-opioid receptors in the brain and spinal cord, blocking pain signals and altering pain perception. Benefits include rapid, potent pain relief in hospital settings, especially post-surgery or severe pain cases, providing short-term, effective analgesia when other routes are unsuitable, with careful regulation due to dependence risks
Oxycodone injectable is primarily used for research or hospital settings and is not widely marketed for general clinical use. Due to its high abuse potential and strict control, injectable oxycodone is regulated as a controlled substance in both the US and EU. In the US, such formulations are regulated by the DEA and FDA, requiring special licenses, and are typically available only for limited clinical or research purposes. In the EU, approval and manufacturing are overseen by EMA, with strict regulatory controls, including licensing, risk management, and pharmacovigilance. For detailed regulatory support, dossier preparation, and compliance, visit PharmaTradz. We help facilitate adherence to regulations for restricted opioid formulations.